ADD CONDITION
Dectomax
Last content change checked dailysee data sync status
- Active ingredient
- Doramectin 10 mg/1 mL
- Other brand names
- Dosage form
- Injection, Solution
- Routes
- Intramuscular
- Subcutaneous
- Prescription status
- Animal
- Pregnancy
- See Pregnancy Use Section
- Lactation
- See Lactation Use Section
- Marketed in the U.S.
- Since 1996
- Label revision date
- November 3, 2025
- Veterinary Document
- Prescribing information, PDF file
- Active ingredient
- Doramectin 10 mg/1 mL
- Other brand names
- Dosage form
- Injection, Solution
- Routes
- Intramuscular
- Subcutaneous
- Prescription status
- Animal
- CSA schedule
- Not a scheduled drug
- Pregnancy
- See Pregnancy Use Section
- Lactation
- See Lactation Use Section
- Marketed in the U.S.
- Since 1996
- Label revision date
- November 3, 2025
- Manufacturer
- Zoetis Inc.
- Registration number
- NADA141061
- NDC root
- 54771-5438
- Veterinary Document
- Prescribing information, PDF file
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
If you are a consumer or patient please visit this version.
Drug Overview
Dectomax (doramectin) is a ready-to-use, sterile solution designed for the treatment and control of various harmful parasites in cattle and swine. In cattle, it effectively targets gastrointestinal roundworms, lungworms, eyeworms, grubs, sucking lice, and mange mites, providing protection against reinfection for specific durations after treatment. For swine, Dectomax is used to manage similar parasitic infections, ensuring the health and well-being of the animals.
The active ingredient, doramectin, works by disrupting the nervous system of the parasites, leading to their elimination. Dectomax-CA1, a specific formulation, is also used to prevent and treat infestations caused by certain larvae, offering additional protection for cattle. This medication is administered through injections, tailored to the weight of the animal, ensuring effective dosing for optimal results.
Uses
You can use this medication for treating and controlling various parasitic infections in cattle and swine. For cattle, it effectively targets gastrointestinal roundworms, lungworms, eyeworms, grubs, sucking lice, and mange mites. This treatment not only helps eliminate these parasites but also provides protection against reinfection for specific durations, depending on the type of parasite.
In swine, the medication is indicated for the treatment and control of gastrointestinal roundworms, lungworms, kidney worms, mange mites, and sucking lice. It addresses both adult and immature stages of these parasites, ensuring comprehensive management of infestations. This can help maintain the health and productivity of your livestock.
Dosage and Administration
When using Dectomax or Dectomax-CA1 for cattle, you should administer it at a dosage of 200 micrograms (mcg) of doramectin per kilogram (kg) of body weight, which is equivalent to 91 mcg per pound (lb). Each milliliter (mL) of the product contains 10 mg of doramectin and 218 mg of ethyl oleate, mixed in a sesame oil vehicle, and is designed to treat cattle weighing up to 110 lb (50 kg). For example, if your cattle weighs 220 lb, you would give them 2 mL, and for a weight of 330 lb, the dosage would be 3 mL. This continues up to 10 mL for cattle weighing 1,100 lb.
For swine, the recommended dosage is higher at 300 mcg of doramectin per kg of body weight, or 136 mcg per lb. Each mL of Dectomax for swine also contains 10 mg of doramectin and 218 mg of ethyl oleate, suitable for treating pigs weighing up to 75 lb (34 kg). For instance, a pig weighing 150 lb would require 2 mL, while a 450 lb pig would need 6 mL. It’s crucial to ensure that each animal receives the full dose based on their current body weight, as underdosing can lead to ineffective treatment and may contribute to the development of resistance in parasites.
What to Avoid
It's important to follow specific guidelines when using this product to ensure safety and effectiveness. You should not use it in female dairy cattle that are 20 months or older, nor in calves intended for veal. Additionally, this product is not safe for other animal species, as it can cause severe adverse reactions, including fatalities in dogs. Always use this restricted drug only as directed, as misuse is against federal law.
Make sure to administer the full dose based on the current body weight of each animal, as underdosing can lead to ineffective treatment and may promote parasite resistance. Avoid slaughtering animals for human consumption within 35 days of treatment, and ensure that water runoff from feedlots does not contaminate streams or ponds. Lastly, do not dispose of drug containers improperly, as this can also lead to water contamination.
Side Effects
Using Dectomax/Dectomax-CA1 is intended solely for cattle and swine, and it is crucial to keep it out of reach of children. This product can lead to severe adverse reactions in other animal species, including fatalities in dogs.
When treating cattle grubs, there may be serious side effects if the larvae are destroyed in critical areas. For instance, killing H. lineatum (a type of cattle grub) near the gullet can lead to bloat, while killing H. bovis in the vertebral canal may result in staggering or paralysis. These reactions can occur with any effective treatment for grubs, not just with Dectomax. If you experience any adverse effects or need more information, please call 1-888-963-8471.
Warnings and Precautions
This product is not intended for human use, so it's crucial to keep it out of reach of children to prevent any accidental exposure. If you have any questions about the product, need to report any adverse effects, or want to obtain a safety data sheet (SDS) that provides detailed safety information, please call 1-888-963-8471.
For your safety, always follow the instructions provided and ensure that you are using the product as intended. If you experience any unexpected reactions or side effects, stop using the product immediately and consult your doctor.
Overdose
It appears that there is no specific information available regarding overdosage for this medication. However, it’s always important to be aware of the potential risks associated with taking more than the recommended dose. If you suspect an overdose, look for signs such as unusual drowsiness, confusion, or difficulty breathing.
In the event of an overdose, it is crucial to seek immediate medical help. You can contact your local emergency services or go to the nearest hospital. Always keep the medication packaging on hand to provide healthcare professionals with important information about the drug. Remember, when in doubt, it’s better to err on the side of caution and get help.
Pregnancy Use
It’s important to know that Dectomax is not recommended for use in pregnant animals, as its safety during pregnancy has not been established. While studies in female cows and sows showed that a dose three times higher than the recommended amount did not affect breeding performance, this does not guarantee safety for all pregnant animals.
If you are caring for a pregnant animal, it’s best to consult your veterinarian. They can provide guidance on the diagnosis, treatment, and management of parasitic infections, ensuring the health and safety of both the mother and her offspring.
Lactation Use
When it comes to breastfeeding, the information provided does not specifically address nursing mothers or lactation (the process of producing milk). This means that there are no clear guidelines or recommendations regarding the use of this medication while breastfeeding.
If you are breastfeeding or planning to breastfeed, it's important to consult with your healthcare provider for personalized advice. They can help you understand any potential risks and make informed decisions about your health and your baby's well-being.
Pediatric Use
When considering medication for your children, it's important to know that safety has been demonstrated in young animals, such as neonatal calves and piglets, even when treated with doses up to three times the recommended amount. This suggests a level of safety, but always consult your healthcare provider for guidance specific to your child's needs.
For administering medication to piglets, using a tuberculin syringe with a 20 gauge, 1-inch needle is recommended to ensure accurate dosing. While this information is based on veterinary practices, it highlights the importance of precise dosing in young animals, which can be a useful reminder for any medication you may be considering for your child. Always prioritize safety and follow professional advice.
Geriatric Use
When it comes to using this medication in older adults, there is no specific information available about how it should be adjusted for dosage or any unique safety concerns. This means that if you or a loved one is an older adult considering this medication, it’s important to consult with a healthcare provider. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.
Renal Impairment
If you have kidney problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations for the medication do not include special monitoring or safety considerations tailored for patients with renal impairment (kidney issues).
Always consult your healthcare provider for personalized advice and to ensure that your treatment plan is safe and effective for your specific health needs. They can provide guidance based on your kidney function and overall health.
Hepatic Impairment
If you have liver problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or precautions related to your condition. This means that there are no tailored recommendations for how the medication may affect you differently due to your liver health.
It's always best to discuss your liver condition with your healthcare provider before starting any new medication. They can provide personalized advice and ensure that your treatment is safe and effective for you.
Drug Interactions
It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. While there are no specific drug interactions or laboratory test interactions noted for this medication, your healthcare provider can help ensure that everything you are taking works well together and is safe for you.
Always feel free to ask questions and share your complete list of medications and any tests you might be undergoing. This way, you can avoid any potential issues and ensure the best possible care.
Storage and Handling
To ensure the safety and effectiveness of your product, store it in a cool place, keeping the temperature below 30°C (86°F). After you first puncture the vial, make sure to use the product within 90 days and limit the number of punctures to a maximum of 25. If you expect to puncture the vial more than 25 times, consider using automatic injection equipment or a repeater syringe for better handling.
When using a draw-off spike or needle with a bore diameter larger than 16 gauge, be sure to discard any remaining product in the vial immediately after use. Dectomax is available in 100 mL, 250 mL, and 500 mL multi-dose glass vials with rubber caps. Finally, dispose of any empty containers responsibly, either in an approved landfill or by incineration.
Additional Information
No further information is available.
FAQ
What is Dectomax?
Dectomax is a ready-to-use, sterile solution containing 1% w/v doramectin, indicated for the treatment and control of various parasites in cattle and swine.
How is Dectomax administered to cattle?
Dectomax is administered by subcutaneous (SC) or intramuscular (IM) injection at a dosage of 200 mcg doramectin per kg of body weight.
What is the recommended dosage for swine?
For swine, Dectomax should be administered at a dosage of 300 mcg doramectin per kg of body weight via IM injection.
What parasites does Dectomax control in cattle?
Dectomax effectively controls gastrointestinal roundworms, lungworms, eyeworms, grubs, sucking lice, and mange mites in cattle.
Are there any contraindications for using Dectomax?
Dectomax should not be used in female dairy cattle 20 months of age or older, in calves to be processed for veal, or in other animal species due to severe adverse reactions.
What precautions should be taken when using Dectomax?
Dectomax is not for human use and should be kept out of reach of children. It should only be used as directed to avoid adverse effects.
Can Dectomax be used in pregnant animals?
Dectomax is not indicated for use in pregnant animals, as safety during pregnancy has not been established.
How should Dectomax be stored?
Store Dectomax below 30°C (86°F) and use it within 90 days of the first puncture.
What should I do if I suspect an adverse reaction?
To report adverse effects or obtain more information, call 1-888-963-8471.
What happens if I underdose Dectomax?
Underdosing may result in ineffective treatment and encourage the development of parasite resistance, so ensure each animal receives a complete dose based on current body weight.
Packaging Info
The table below lists each NDC Code for Dectomax (doramectin) veterinary formulations. Columns show Packaging, Formulation Type, and Active Ingredient Strength.
Details | ||||
|---|---|---|---|---|
| Injection, Solution | 10 mg/1 mL | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
| ||||
| Injection, Solution | 10 mg/1 mL | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
| ||||
| Injection, Solution | 10 mg/1 mL | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
| ||||
Drug Information (PDF)
This PDF provides official product information for Dectomax, which is intended for animal use only.
Description
Dectomax/Dectomax-CA1 is a ready-to-use, colorless to pale yellow, sterile solution that contains 1% w/v doramectin, equivalent to 10 mg/mL.
Uses and Indications
This drug is indicated for the treatment and control of various parasitic infections in cattle and swine.
In cattle, it is indicated for the treatment and control of gastrointestinal roundworms, including adults and fourth stage larvae of Ostertagia ostertagi (including inhibited larvae), O. lyrata, Haemonchus placei, Trichostrongylus axei, T. colubriformis, T. longispicularis (adults), Cooperia oncophora, C. pectinata (adults), C. punctata, C. surnabada (syn. mcmasteri), Bunostomum phlebotomum (adults), Strongyloides papillosus (adults), Oesophagostomum radiatum (adults), and Trichuris spp. (adults). It is also indicated for the treatment of lungworms (Dictyocaulus viviparus), eyeworms (Thelazia spp.), and grubs (Hypoderma bovis and H. lineatum). Additionally, it is effective against sucking lice (Haematopinus eurysternus, Linognathus vituli, Solenopotes capillatus) and mange mites (Psoroptes bovis and Sarcoptes scabiei).
This drug effectively controls infections and protects cattle from reinfection with Cooperia oncophora and Haemonchus placei for 14 days, Ostertagia ostertagi for 21 days, and C. punctata, Oesophagostomum radiatum, and Dictyocaulus viviparus for 28 days after treatment. It is also indicated for the prevention and treatment of infestations caused by larvae of Cochliomyia hominivorax (myiasis), with prevention of reinfestation for 21 days.
In swine, this drug is indicated for the treatment and control of gastrointestinal roundworms, including adults and fourth stage larvae of Ascaris suum, Oesophagostomum dentatum, Oesophagostomum quadrispinulatum (adults), Strongyloides ransomi (adults), and Hyostrongylus rubidus (adults). It is also indicated for the treatment of lungworms (Metastrongylus spp.), kidney worms (Stephanurus dentatus), mange mites (Sarcoptes scabiei var. suis), and sucking lice (Haematopinus suis).
Limitations of use include adherence to established guidelines for the management of parasitic infections in cattle and swine, ensuring appropriate dosing and treatment intervals to maximize efficacy and minimize resistance development.
Dosage and Administration
Dectomax/Dectomax-CA1 should be administered to cattle at a dosage of 200 mcg doramectin per kg (91 mcg/lb) of body weight. Each mL of Dectomax/Dectomax-CA1 contains 10 mg of doramectin and 218 mg of ethyl oleate in a sesame oil vehicle, which is sufficient to treat 110 lb (50 kg) of body weight. The following dosing guidelines based on body weight are recommended:
For a body weight of 110 lb: administer 1 mL
For a body weight of 220 lb: administer 2 mL
For a body weight of 330 lb: administer 3 mL
For a body weight of 440 lb: administer 4 mL
For a body weight of 550 lb: administer 5 mL
For a body weight of 660 lb: administer 6 mL
For a body weight of 770 lb: administer 7 mL
For a body weight of 880 lb: administer 8 mL
For a body weight of 990 lb: administer 9 mL
For a body weight of 1,100 lb: administer 10 mL
For swine, Dectomax should be administered at a dosage of 300 mcg doramectin per kg (136 mcg/lb) of body weight. Each mL of Dectomax contains 10 mg of doramectin and 218 mg of ethyl oleate in a sesame oil vehicle, which is sufficient to treat 75 lb (34 kg) of body weight. The following dosing guidelines based on body weight are recommended:
For a body weight of 15 lb: administer 0.2 mL
For a body weight of 30 lb: administer 0.4 mL
For a body weight of 45 lb: administer 0.6 mL
For a body weight of 60 lb: administer 0.8 mL
For a body weight of 75 lb: administer 1.0 mL
For a body weight of 150 lb: administer 2.0 mL
For a body weight of 225 lb: administer 3.0 mL
For a body weight of 300 lb: administer 4.0 mL
For a body weight of 375 lb: administer 5.0 mL
For a body weight of 450 lb: administer 6.0 mL
It is critical to avoid underdosing. Each animal must receive a complete dose based on its current body weight to ensure effective treatment and to prevent the development of parasite resistance.
Contraindications
Use of this product is contraindicated in the following situations:
Female dairy cattle 20 months of age or older should not be treated with this product due to potential adverse effects.
The product is not to be administered to calves intended for veal processing, as it may affect meat quality and safety.
This product is contraindicated in other animal species, as severe adverse reactions, including fatalities, have been reported in dogs.
Additionally, it is essential to adhere to the following guidelines to prevent misuse and ensure safety:
Underdosing is prohibited; each animal must receive a complete dose based on current body weight to avoid ineffective treatment and the development of parasite resistance.
Slaughter for human consumption is not permitted within 35 days of treatment.
Water runoff from feedlots must not enter streams or ponds to prevent environmental contamination.
Direct application of the product or improper disposal of drug containers that may contaminate water sources is strictly prohibited.
Warnings and Precautions
The product is strictly not intended for human use and should be handled with caution. It is imperative to keep this product out of reach of children to prevent accidental exposure.
For healthcare professionals, it is essential to consult the safety data sheet (SDS) for comprehensive occupational safety information related to the handling and use of this product. The SDS provides critical details that can aid in ensuring safe practices in a clinical or laboratory setting.
In the event of adverse effects observed in users, healthcare professionals are encouraged to report these incidents. For further information regarding the product or to obtain an SDS, please contact the designated helpline at 1-888-963-8471. This resource is available to assist in addressing any concerns or inquiries related to the safe use of the product.
Side Effects
Patients using Dectomax/Dectomax-CA1, which is specifically developed for cattle and swine, should be aware of the potential for serious adverse reactions. This product is not intended for human use and must be kept out of reach of children. The safety data sheet (SDS) provides more detailed occupational safety information, and adverse effects in users can be reported by calling 1-888-963-8471.
Severe adverse reactions have been noted in non-target species, particularly in dogs, where fatalities may occur. Additionally, the destruction of Hypoderma larvae, specifically during critical developmental stages, can lead to significant host-parasite reactions. For instance, the elimination of H. lineatum when located in the tissue surrounding the gullet may result in bloat, while the destruction of H. bovis in the vertebral canal may lead to staggering or paralysis. It is important to note that these reactions are not unique to Dectomax treatment but can occur with any effective treatment of grubs.
Given these potential risks, it is crucial for practitioners to adhere strictly to the recommended usage guidelines and to monitor treated animals closely for any adverse effects.
Drug Interactions
There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.
Packaging & NDC
The table below lists each NDC Code for Dectomax (doramectin) veterinary formulations. Columns show Packaging, Formulation Type, and Active Ingredient Strength.
Details | ||||
|---|---|---|---|---|
| Injection, Solution | 10 mg/1 mL | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
| ||||
| Injection, Solution | 10 mg/1 mL | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
| ||||
| Injection, Solution | 10 mg/1 mL | ||
Product details Regulatory status — Marketed All current FDA data sets list this NDC as actively marketed. FDA record dates for this NDC:
Active ingredients
| ||||
Pediatric Use
Safety has been demonstrated in neonatal calves and piglets treated with doses up to three times the recommended amount. In studies involving male (bulls and boars) and female (cows and sows) subjects during critical reproductive phases such as folliculogenesis, implantation, organogenesis, and throughout gestation, administration of a dose three times the recommended level did not adversely affect breeding performance.
For the administration of this product in swine, it is recommended to utilize a tuberculin syringe with a 20 gauge × 1" needle to ensure accurate dosing in piglets.
Geriatric Use
There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments or safety concerns. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as they may have altered pharmacokinetics and pharmacodynamics. Close monitoring is recommended to ensure safety and efficacy in this population.
Pregnancy
Dectomax is not indicated for use in pregnant animals, and safety during pregnancy has not been established. In studies involving female cows and sows during critical reproductive phases, including folliculogenesis, implantation, organogenesis, and throughout gestation, administration of a dose three times the recommended level did not adversely affect breeding performance. However, due to the lack of established safety data, it is essential for healthcare professionals to consult with a veterinarian for guidance on the diagnosis, treatment, and control of parasitism in pregnant animals.
Lactation
There is no specific information available regarding the use of this medication in lactating mothers. The effects on breastfed infants and the excretion of the drug in human milk have not been addressed in the prescribing information. Healthcare professionals should consider the potential risks and benefits when prescribing this medication to lactating mothers.
Renal Impairment
Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.
Hepatic Impairment
Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.
Overdosage
There is currently no specific information available regarding overdosage for this medication. Healthcare professionals are advised to monitor patients closely for any signs of adverse effects or symptoms that may arise from excessive dosing.
In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Patients should be evaluated for potential complications, and appropriate interventions should be implemented based on clinical judgment.
For further guidance, healthcare professionals may refer to established protocols for managing drug overdosage or consult a poison control center.
Nonclinical Toxicology
In nonclinical studies assessing teratogenic effects, it was observed that a dose three times the recommended amount did not adversely affect breeding performance in both male (bulls and boars) and female (cows and sows) subjects during critical reproductive phases, including folliculogenesis, implantation, organogenesis, and throughout gestation.
Regarding non-teratogenic effects, extensive studies have established a significant safety margin for Dectomax injection in cattle and swine. Trials conducted in the United States revealed no toxic signs in cattle administered doses up to 25 times the recommended level, nor in swine receiving doses up to 10 times the recommended level. Additionally, safety was confirmed in neonatal calves and piglets treated with doses up to three times the recommended amount.
The primary mode of action of macrocyclic lactones involves the modulation of chloride ion channel activity within the nervous systems of nematodes and arthropods. These compounds bind to specific receptors that enhance membrane permeability to chloride ions, leading to the inhibition of electrical activity in nerve cells of nematodes and muscle cells of arthropods, ultimately resulting in paralysis and death of the parasites. In mammals, the neuronal receptors targeted by macrocyclic lactones are primarily located within the central nervous system (CNS), where only negligible concentrations of doramectin are present.
Postmarketing Experience
Adverse reactions, including fatalities in dogs, have been reported following the use of Dectomax/Dectomax-CA1 in species other than cattle and swine. Instances of parasite resistance have been documented, indicating that resistance may develop to any dewormer, with reports suggesting this phenomenon occurs across most classes of dewormers.
A decrease in the effectiveness of the drug over time, as determined by fecal egg count reduction tests, may suggest the emergence of resistance to the administered dewormer. Additionally, the destruction of Hypoderma larvae (cattle grubs) during critical periods when these grubs are located in vital areas may lead to undesirable host-parasite reactions, including potential fatalities.
Specific adverse effects have been noted when H. lineatum is killed while in the tissue surrounding the gullet, which may result in bloat. Similarly, the elimination of H. bovis when located in the vertebral canal has been associated with staggering or paralysis. It is important to note that cattle treated with Dectomax after the conclusion of the heel fly season may safely receive re-treatment during the winter for internal parasites, mange mites, or sucking lice, without the risk of grub-related reactions.
Patient Counseling
Healthcare providers should emphasize to patients that it is a violation of Federal law to use this product other than as directed in the labeling. Patients are advised to consult their veterinarian for assistance in the diagnosis, treatment, and control of parasitism.
It is crucial to ensure that each animal receives a complete dose based on its current body weight, as underdosing may lead to ineffective treatment and encourage the development of parasite resistance. The product is intended for subcutaneous (SC) injection in cattle only and for intramuscular (IM) injection in both swine and cattle.
Patients should be informed that cattle treated with Dectomax after the end of the heel fly season may be re-treated during the winter for internal parasites, mange mites, or sucking lice without the risk of grub-related reactions. A planned parasite control program is recommended to optimize treatment outcomes.
Healthcare providers should also discuss the importance of monitoring treatment effectiveness following the use of any dewormer. This can be achieved through fecal examinations or other diagnostic tests, as well as by maintaining a parasite management history to determine if the product is appropriate for the herd. A decrease in a drug's effectiveness over time, as indicated by fecal egg count reduction tests, may suggest the development of resistance to the dewormer administered, necessitating adjustments to the parasite management plan.
Patients must be made aware of the specific withdrawal periods associated with this product: do not slaughter cattle for human consumption within 35 days of treatment, and do not use in female dairy cattle 20 months of age or older. Additionally, a withdrawal period has not been established for this product in preruminating calves, and it should not be used in calves intended for veal. For swine, do not slaughter for human consumption within 24 days of treatment.
Finally, it is important to inform patients that Dectomax/Dectomax-CA1 has been developed specifically for use in cattle and swine only. The product should not be used in other animal species, as severe adverse reactions, including fatalities in dogs, may occur. For more detailed occupational safety information, patients can refer to the safety data sheet (SDS) and are encouraged to report any adverse effects or seek additional information by calling 1-888-963-8471.
Storage and Handling
Dectomax is supplied in a 100 mL multi-dose, rubber-capped glass vial. Additionally, Dectomax/Dectomax-CA1 is available in 250 mL and 500 mL multi-dose, rubber-capped glass vials.
Storage conditions require that the product be kept below 30°C (86°F). It is essential to use the product within 90 days of the first puncture, with a maximum of 25 punctures allowed. For situations where more than 25 punctures are anticipated, the use of automatic injection equipment or a repeater syringe is recommended.
When utilizing a draw-off spike or needle with a bore diameter larger than 16 gauge, any remaining product in the vial should be discarded immediately after use.
Containers should be disposed of in an approved landfill or by incineration to ensure proper waste management.
Additional Clinical Information
No further data are available.
Drug Information (PDF)
This document includes the full labeling information for Dectomax, as submitted by Zoetis Inc. for veterinary use. It may include dosage by species, withdrawal periods, and administration instructions.